Cardiac Surgery
Von Kier, Wade C, Cheung V, Royston D. "Benefit of Intraoperative [TEG® Analyzer] Algorithm to Reduce Platelet Transfusion Associated Adverse Outcome in Higher Risk Cardiac Surgery Patients". Abstract presented at the American Society of Anesthesiologists, October 16, 2001.
Royston D, von-Kier S "Reduced Haemostatic Factor Transfusion Using Heparinase-Modified [Thrombelastograph® Analysis] during Cardiopulmonary Bypass." British Journal of Anaesthesia. 2001; 86:575-578.
von Kier S, Royston D, Wade C. "[TEG® Analyzer] R-time is Directly Related to Hirudin Concentration in Whole Blood Following Stimulation with the Snake Venom Ecarin." Anesthesia and Analgesia. 2001:V93:No.3A: Supplement; A.
Nielsen VG, Geary BT. "Hepatoenteric Ischemia-Reperfusion Increases Circulating Heparinoid Activity in Rabbits." Journal of Critical Care. 2000; V15:4; 142-146.
"A Retrospective Survey of Fibrinolysis as an Indicator of Poor Outcome after Cardiopulmonary Bypass and a Possible Early Sign of Systemic Inflammation Syndrome." European Journal of Anaesthesiology. 2000; 17; 173-176.
Robbins P, Von Kier S, Forrest M, Royston D. "Activated Clotting Times are
Shortened by Tranexamic Acid." Anesthesiology. Sept. 1998, V89, No 3A, A962.
Von Kier S, Royston D. "Reduced Hemostatic Factor Transfusion using
Heparinase-Modified [Thrombelastograph® Analysis]
(TEG[®]) During Cardiopulmonary Bypass (CPB)." Anesthesiology.
Sept. 1998, V89, No. 3A, A911.
Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "[Thrombelastograph®
Analysis]
Decreases Transfusion Requirements after Cardiac Surgery." Anesthesiology. Sept.
1998, V89, No3A, A246.
Stammers AH, Bruda NL, Gonano C, Hartmann T. "Point-of-care coagulation
monitoring: applications of the [Thrombelastograph® Analyzer]." Anesthesia. 1998,53 (Suppl
2), pp 1-80.
Spiess BD. "Perioperative Coagulation Monitoring." Perioperative
Transfusion Medicine. 1998.
Kettner SC, Kozek SA, Groetzner JP, Gonano C, Schellongowski A, Kucera M, ZimpferM.
"Effects of hypothermia on [Thrombelastograph®
analysis] in patients undergoing cardiopulmonary
bypass." British Journal of Anaesthesia. 1998;80:313-317.
Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver WC, Schaff HV. "The
Relation between the Platelet-activated Clotting Test (HemoSTATUS) and Blood Loss after
Cardiopulmonary Bypass." Anesthesiology. 1998;88:962-9.
Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Intraoperative
[Thrombelastograph® Analysis] (TEG[®]) Reduces Transfusion Requirements." Anesth Analg.
1998;86;SCA101.
Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Heparinase-Modified
[Thrombelastograph® Analysis] During Bypass Predicts Mediastinal Tube Drainage." Anesth
Analg. 1998;86;S104.
Takeda T, Kohro S, Yamakage M, et al. "Effect of Recycled Autologous Blood
Transfusion on in Vitro Blood Coagulability and Fibrinolysis." Anesth Analg. 1998:86;S110.
Shulman G, McQuitty C, Vertrees RA, Conti VR. "Acute Normovolemic Red Cell
Exchange for Cardiopulmonary Bypass in Sickle Cell Disease." Ann Thorac Surg.
1998;65.
Ficek SJ, Stammers A, Ubeydullah D, et al. "Hemostatic Assessment of Patients
Undergoing Intraaortic Balloon Pump Therapy." Journal of Extra-Corporeal
Technology. June 1997. V29, No 2.
McCarthy RJ, Tuman KJ, El-Ganzouri N, Ivankovich AD. "Influence of Heparin
Reversal Methods on Whole Blood [Thrombelastograph®] Measures of Coagulation." Anesth
Analg. 1997;84;S104.
O'Connor CJ, Tuman KJ, McCarthy RJ, McCarthy WE, Ivankovich AD. "Multivariate
Predictors of Bleeding and Transfusion in Reoperative CABG Surgery." Anesth Analg.
1997;84;S114.
Wolman RL, Bardwell PS, Embrey J, Bowman T, Michael J, O'Rourke P, Roberts J, Weiss J,
Shapiro J. "Empirical Versus [TEG®]-Guided Transfusion Practices During Cardiac
Surgery." Anesth Analg. 1997;84;S223.
Tomiyama Y, Yasumoto S, Sakata S, Kitahata H, Kimura H, Oshita S. "Coagulation
Status of the Whole Blood Preoperatively Obtained in the Operating Room and Preserved at
Room Temperature [Thrombelastograph®] Evaluation." Anesthesiology. September
1996. V85. No. 3A.
Spiess BD. "Coagulation Monitoring in the perioperative period." Acta
Anaestheisologica Scandinavica. 1996;109;V40:M29.
Soltow LO, Spiess BD, Wahr J, Herskowitz A, et al. "Does Acadesine Contribute to
Hypocoagulability after CABG Surgery." Anesth Analg. 1996;82,SCA97.
Zimmermann J, McIntosh C, Clementi W, et al. "Heparin Reversal with NeutralaseTM
(HEPARINASE I) in Adult Male Volunteers. Anesth Analg. 1996;82,SCA93.
Robbins P, Forrest M, von Kier S, Royston D. "Can the
[Thrombelastograph® Analyzer] (TEG[®])
Predict Dose Requirement for Aprotinin Therapy?" Anesthesiology. Sept. 1996.
V85, No. 3A.
Spiess BD. "[Thrombelastograph® Analysis] and Cardiopulmonary Bypass." Seminars in
Thrombosis and Hemostasis. 1995. V21 Supplement 4.
Shore-Lesserson L, Reich DL, DePerio M, Silvay G. "Autologous Platelet-Rich
Plasmapheresis: Risk Versus Benefit in Repeat Cardiac Operations." Anesth Analg. 1998;81:229-35.
Spiess BD, Gilles B, Chandler W, Verrier E. "Changes in Transfusion Therapy and
Reexploration Rate After Institution of a Blood Management Program in Cardiac Surgical
Patients." Journal of Cardiothoracic and Vascular Anesthesia. April 1995: V9,
No.2. pp168-173.
Thwaites BK, Mongan PD, Brown RS. [Thrombelastograph®] Evidence of Fibrinolysis
Strongly Predicts Excess Bleeding After Cardiopulmonary Bypass." Anesthesia &
Analgesia. April 1995;V80, No. 4S.
Etzioni DA, Tobias MD, Jobes DR. "[Thrombelastograph®
Analysis] Results are Easily Affected
by Sample and Technique." Anesthesia & Analgesia. April 1995. V80, No. 4S.
Copeland JG, Tsau PH, Arabia FA, Xie T. "Correlation of Clinical Embolic Events
with Coagulability in a Patient with a Total Artificial Heart." Journal of Heart
and Lung Transplantation. 1995; V14, No. 5.
McCarthy RJ, Tuman KJ, Holm WE, Ivankovich AD. "Effects of Aspirin on Homologous
Blood Requirements after Repeat Cardiac Operations." Anesthesia & Analgesia.
Feb. 1995; V80, No. 2S.
McCarthy RJ, Tuman KJ, Bednar LA, Holm WE, Ivankovich AD. "Effects of Heparinase
and Protamine on Whole Blood Coagulation in the Presence and Absence of Heparin." Anesthesiology.
September 1994;81(3A).
Spiess BD, Soltow LO. "[Thrombelastograph®
Analysis] is Best Preserved in High Dose Aprotinin
Treated Repeat CABG Patients." Anesthesiology. September 1994;81(3A).
Spiess BD, Soltow L, Dobbyn R, Chandler WL. "The Effects of Cardiopulmonary Bypass
on Shear Moduleus in a Clinical Series of Cardiopulmonary Bypass Patients as Measured by
[Thrombelastograph® Analysis] ." Anesthesiology. September 1994;81(3A).
MaGuire DP, McNulty SE. "Heparin Bonded Pulmonary Artery Catheters May Affect the
Thromboelastogram and Activated Coagulation Time." Anesthesiology. September
1994;81(3A).
Spiess BD, Soltow L, Dobbyn R. "[Thrombelastograph®
Analysis] Preoperatively can Predict
Postoperative Risk of Severe Hemorrhage in Valve Surgery: A Report of a Clinical
Series." Anesthesiology. September 1994; 81(3A).
Tuman KJ, McCarthy R, Djuric M, Rizzo BA, Ivankovich A. "Evaluation of Coagulation
During Cardiopulmonary Bypass with a Heparinase-Modified
[Thrombelastograph®] Assay."
Journal of Cardiothoracic and Vascular Anesthesia. (April), 1994:V8, No.2,
pp144-149.
McCarthy R, Tuman K, Ivankovich AD. "Heparinase Enhanced Whole Blood
[Thrombelastograph® Analysis] During Cardiopulmonary Bypass is Predictive of Coagulation Status
after Protamine Reversal of Heparin." Anesthesiology. Sept. 1993, V79, No. 3A.
McCarthy R, Tuman K, Djurie M, Rizzo V, Ivankovich AD. "Effect of Heparinase on
Viscoelastic Coagulation Measurements in the Presence and Absence of Heparin." Anesthesiology.
Sept. 1993, V79, No. 3A.
Wall MH, Spiess BD, Gillies B, Chandler WL. "[Thrombelastograph®
Analysis] With Added
Heparinase or Protamine Sulfate During Cardiopulmonary Bypass." Anesthesiology.
Sept. 1993, V79, No.3A.
Essels JH, Martin TJ, Salinas J, Thompson JM, Smith VC. "Comparison of
[Thrombelastograph® Analysis] to Bleeding Time and Standard Coagulation Tests in Patients After
Cardiopulmonary Bypass." Journal of Cardiothoracic and Vascular Anesthesia.
August 1993, V7, No. 4, pp410-415.
Dorman BH, Spinale FG, Bailey MK, Kratz JM, Roy RC. "Identification of patients at
risk for excessive blood loss during coronary artery bypass surgery: [Thrombelastograph®
analysis]
versus coagulation screen." Anesth Analg April 1993; V76;694-700.
McCarthy R, Tuman K, Djuric M, Rizzo V, Ivankovich AD. "Use of Heparinase to
Evaluate Coagulation During Cardiopulmonary Bypass with Systemic Heparinization." Anesthesiology.
September 1992;77(3A).
Mongan P, Hosking M. "The Role of Desmopressin Acetate in Patients Undergoing
Coronary Artery Bypass Surgery." Anesthesiology. 1992:77:38-46.
Baeuerle JJ, Mongan PD, Hosking MP. "An Assessment of the Duration of
Cephapirin-Induced Coagulation Abnormalities as Measured by the [Thrombelastograph®
Analyzer]." Anesthesiology.
1991:75(3A).
Wong CA, Jones JH, Wade L. "Comparison of Act and TEG[®] in Patients Receiving
Autologous Platelet-Rich-Plasma during Cardiac Surgery." Anesthesiology.
1991:75(3A).
Lake, CB, ed. "Intraoperative Evaluation of Haemostasis." Clinical
Monitoring. Philadelphia: WB Saunders, 1990 pp 558-574.
Spiess, BD. "Coagulation Function in Operating Room." The Hemorrhagic
Disorders, Anesthesia Clinics of North America. WB Saunders. 1990:13:481-499.
Weiss J, McNulty S, Schmitz T. "[Thrombelastograph®] Evaluation of the Effect of
Cell Saver Blood on Coagulation in the Post Cardiopulmonary Bypass Patient." Anesthesiology.
1990:72(3A).
Spiess BD, Ivankovich AD. "[Thrombelastograph®
Analysis]: A Coagulation-Monitoring Technique
applied to Cardiopulmonary Bypass." Monograph of the Society of Cardiovascular Anesthesia.
Ed. Ellison and Jobes: 1988.
Spiess B, Tuman K, McCarthy R, DeLaria A, Schillo R, Ivankovich AD.
"[Thrombelastograph® Analysis] as an Indicator of Post-Cardiopulmonary Bypass
Coagulopathies." Journal of Clinical Monitoring. 1987:3:25-30.
Tuman KJ, Spiess B, McCarthy R, Ivankovich AD. "Effects of Progressive Blood Loss
on Coagulation as Measured by [Thrombelastograph®
Analysis]." Anesth Analog.
1987:66:856-63.
Tuman K, Spiess B, Schoen R, Ivankovich AD. " Use of [Thrombelastograph®
Analysis] in the
Management of von Willebrand's Disease During Cardiopulmonary Bypass." Journal of
Cardiothoracic Anesthesia. 1987:1(4):321-324. Return to top
|